IMM Immupharma Plc

TIDMIMM

RNS Number : 1388X

Immupharma PLC

04 May 2016

 
    4 MAY 2016 
 

ANNUAL REPORT AND ACCOUNTS

NOTICE OF ANNUAL GENERAL MEETING: 26 MAY 2016

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2015 has been posted to shareholders.

The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.

The Company's Annual General Meeting will be held on Thursday 26 May 2016 at 10:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

 
                                    -Ends- 
 
 
                         For further information please 
                                    contact: 
     ImmuPharma plc (www.immupharma.org)                + 44 (0) 20 7152 4080 
                              Tim McCarthy, Chairman 
                    Lisa Baderoon, Head of Investor Relations 
      Twitter: @immupharma                              + 44 (0) 7721 413496 
 
      Panmure, Gordon (UK) Limited, NOMAD & Broker       +44 (0) 20 7886 2500 
                 Fred Walsh / Duncan Monteith, Corporate Finance 
                    Charles Leigh-Pemberton, Corporate Broking 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSSSLFWDFMSELI

(END) Dow Jones Newswires

May 04, 2016 02:01 ET (06:01 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024